Biogen (BIIB)

Cost of Revenue

$1.18B

Quarterly · Period ending: · USD

BIIB logo

BIIB Cost of Revenue

Latest reported$1.18B
BIIB Quarterly Cost of Revenue ($0.00 → $1.18B)
High-resolution chart · PNG

BIIB cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
35,202,000
29,146,000
32,753,000
33,027,000
30,795,000
28,623,000
53,305,000
21,400,000
18,100,000
18,300,000
40,909,000
13,100,000
11,200,000
9,200,000
28,088,000
8,000,000
6,700,000
7,400,000
21,325,000
6,500,000
100,000
600,000
0
200,000
100,000
200,000
9,048,000
100,000
300,000
700,000
1,300,000
1,300,000
1,900,000
1,000,000
-43,500,000
17,900,000
15,200,000
12,700,000
11,800,000
11,200,000
10,000,000
10,300,000
8,800,000
9,300,000
9,400,000
8,000,000
7,300,000
6,800,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.